Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets, Volume 15 - Number 14
Editorial
Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met
, 15(14): 1261 - 1262E. Giovannetti and L.G. Leon
DOI: 10.2174/1389450115666141107104844
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
, 15(14): 1263 - 1272Shigehiro Yagishita and Akinobu Hamada
DOI: 10.2174/1389450115666141110154838
Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target
, 15(14): 1273 - 1283Eduardo Castanon, Patricia Martin, Christian Rolfo, Juan P. Fusco, Lucia Ceniceros, Jairo Legaspi, Marta Santisteban and Ignacio Gil-Bazo
DOI: 10.2174/138945011514141216092935
The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
, 15(14): 1284 - 1292Francesco Passiglia, Nele Van Der Steen, Luis Raez, Patrick Pauwels, Ignacio Gil-Bazo, Edgardo Santos, Daniele Santini, Giovanni Tesoriere, Antonio Russo, Giuseppe Bronte, Karen Zwaenepoel, Federico Cappuzzo and Christian Rolfo
DOI: 10.2174/138945011514141216092739
EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
, 15(14): 1293 - 1301Reza Nedaeinia, Amir Avan, Mostafa Manian, Rasoul Salehi and Majid Ghayour-Mobarhan
DOI: 10.2174/1389450115666141125123003
Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress
, 15(14): 1302 - 1311Sharareh Gholamin, Hamid Fiuji, Mina Maftouh, Reza Mirhafez, Fatemeh Homaei Shandiz and Amir Avan
DOI: 10.2174/1389450115666141107105456
Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib
, 15(14): 1312 - 1321Abolfazl Avan, Auke D. Adema, Eveline K. Hoebe, Charlotte M. Huijts, Amir Avan, Gareth J. Veal, Rob Ruijtenbeek, Katja Wosikowski and Godefridus J. Peters
DOI: 10.2174/1389450115666141107110321
The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
, 15(14): 1322 - 1330Letizia Porcelli, Elisa Giovannetti, Yehuda G. Assaraf, Gerrit Jansen, George L. Scheffer, Ietje Kathman, Amalia Azzariti, Angelo Paradiso and Godefridus J. Peters
DOI: 10.2174/1389450116666141205145620
Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
, 15(14): 1331 - 1340Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti
DOI: 10.2174/1389450116666141205160924
The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
, 15(14): 1341 - 1353Fiona H. Tan, Tracy L. Putoczki, Stanley S. Stylli and Rodney B. Luwor
DOI: 10.2174/1389450115666141120104146
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net